Fever for days: A challenging case of dalbavancin-induced fever
Dalbavancin is a novel long acting lipoglycopeptide antibiotic with a favorable safety profile approved for treating Acute Bacterial Skin and Skin Structure Infections (ABSSSI) caused by Gram-positive organisms. Given its long half-life, a two-dose regimen can provide effective systemic therapy for...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-01-01
|
| Serie: | IDCases |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2214250924002142 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|